Stavros G. Vizirgianakis - Jan 15, 2025 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role
Director
Signature
/s/ Stavros G. Vizirgianakis
Stock symbol
APYX
Transactions as of
Jan 15, 2025
Transactions value $
$0
Form type
4
Date filed
1/17/2025, 04:07 PM
Previous filing
Aug 19, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued pursuant to the Issuer's Director Compensation Program, as amended, which provides for the issuance of a stock option to non-employee directors with an exercise price equal to the closing price of the Issuer's common stock on its principal exchange on the second trading day following the Issuer's release of its preliminary 2024 revenue. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.